Linked Life Data

20645530

Source:http://linkedlifedata.com/resource/pubmed/id/20645530

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2010-7-21
pubmed:abstractText
Ustekinumab, a fully human immunoglobulin (Ig) G1K monoclonal antibody directed against the p40 subunit of interleukin (IL)-12/23, has demonstrated efficacy in patients with moderate-to-severe psoriasis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1545-9616
pubmed:author
pubmed:issnType
Print
pubmed:volume
9
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
677-83
pubmed:dateRevised
2011-7-29
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Effects of ustekinumab administration on primate/human antigen-recall and humoral immune response functions.
pubmed:affiliation
Centocor Research & Development, Inc., Malvern, PA, USA. CBrodmer@its.jnj.com
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase I